This report studies the Gene Therapy on Cardiovascular Disease market, covering market size for segment by type (Viral Gene Therapy, Non-Viral Gene Therapy, etc.), by application (Heart Disease, Vascular Disease, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Renovacor, Gene Biotherapeutics, AskBio, Human Stem Cells Institute, Novartis, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Gene Therapy on Cardiovascular Disease from 2017-2022, and provides extensive market forecasts from 2023-2031 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Gene Therapy on Cardiovascular Disease market.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of Gene Therapy on Cardiovascular Disease including:
Renovacor
Gene Biotherapeutics
AskBio
Human Stem Cells Institute
Novartis
...
Market split by Type, can be divided into:
Viral Gene Therapy
Non-Viral Gene Therapy
Market split by Application, can be divided into:
Heart Disease
Vascular Disease
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
TABLE OF CONTENTS
Table of Contents
Chapter 1 Gene Therapy on Cardiovascular Disease Market Overview
1.1 Gene Therapy on Cardiovascular Disease Definition
1.2 Global Gene Therapy on Cardiovascular Disease Market Size Status and Outlook (2017-2031)
1.3 Global Gene Therapy on Cardiovascular Disease Market Size Comparison by Region (2017-2031)
1.4 Global Gene Therapy on Cardiovascular Disease Market Size Comparison by Type (2017-2031)
1.5 Global Gene Therapy on Cardiovascular Disease Market Size Comparison by Application (2017-2031)
1.6 Global Gene Therapy on Cardiovascular Disease Market Size Comparison by Sales Channel (2017-2031)
1.7 Gene Therapy on Cardiovascular Disease Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
Chapter 2 Gene Therapy on Cardiovascular Disease Market Segment Analysis by Player
2.1 Global Gene Therapy on Cardiovascular Disease Sales and Market Share by Player (2020-2022)
2.2 Global Gene Therapy on Cardiovascular Disease Revenue and Market Share by Player (2020-2022)
2.3 Global Gene Therapy on Cardiovascular Disease Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Gene Therapy on Cardiovascular Disease Market Segment Analysis by Type
3.1 Global Gene Therapy on Cardiovascular Disease Market by Type
3.1.1 Viral Gene Therapy
3.1.2 Non-Viral Gene Therapy
3.2 Global Gene Therapy on Cardiovascular Disease Sales and Market Share by Type (2017-2022)
3.3 Global Gene Therapy on Cardiovascular Disease Revenue and Market Share by Type (2017-2022)
3.4 Global Gene Therapy on Cardiovascular Disease Average Price by Type (2017-2022)
3.5 Leading Players of Gene Therapy on Cardiovascular Disease by Type in 2022
3.6 Conclusion of Segment by Type
Chapter 4 Gene Therapy on Cardiovascular Disease Market Segment Analysis by Application
4.1 Global Gene Therapy on Cardiovascular Disease Market by Application
4.1.1 Heart Disease
4.1.2 Vascular Disease
4.2 Global Gene Therapy on Cardiovascular Disease Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of Gene Therapy on Cardiovascular Disease by Application in 2022
4.4 Conclusion of Segment by Application
Chapter 5 Gene Therapy on Cardiovascular Disease Market Segment Analysis by Sales Channel
5.1 Global Gene Therapy on Cardiovascular Disease Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Gene Therapy on Cardiovascular Disease Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of Gene Therapy on Cardiovascular Disease by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Gene Therapy on Cardiovascular Disease Market Segment Analysis by Region
6.1 Global Gene Therapy on Cardiovascular Disease Market Size and CAGR by Region (2017-2031)
6.2 Global Gene Therapy on Cardiovascular Disease Sales and Market Share by Region (2017-2022)
6.3 Global Gene Therapy on Cardiovascular Disease Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Gene Therapy on Cardiovascular Disease Market Share by Type
6.4.3 North America Gene Therapy on Cardiovascular Disease Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Gene Therapy on Cardiovascular Disease Market Share by Type
6.5.3 Europe Gene Therapy on Cardiovascular Disease Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Gene Therapy on Cardiovascular Disease Market Share by Type
6.6.3 Asia-Pacific Gene Therapy on Cardiovascular Disease Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Gene Therapy on Cardiovascular Disease Market Share by Type
6.7.3 South America Gene Therapy on Cardiovascular Disease Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Gene Therapy on Cardiovascular Disease Market Share by Type
6.8.3 Middle East & Africa Gene Therapy on Cardiovascular Disease Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Gene Therapy on Cardiovascular Disease Players
7.1 Renovacor
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Gene Biotherapeutics
7.3 AskBio
7.4 Human Stem Cells Institute
7.5 Novartis
Chapter 8 Upstream and Downstream Analysis of Gene Therapy on Cardiovascular Disease
8.1 Industrial Chain of Gene Therapy on Cardiovascular Disease
8.2 Upstream of Gene Therapy on Cardiovascular Disease
8.3 Downstream of Gene Therapy on Cardiovascular Disease
Chapter 9 Development Trend of Gene Therapy on Cardiovascular Disease (2023-2031)
9.1 Global Gene Therapy on Cardiovascular Disease Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global Gene Therapy on Cardiovascular Disease Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global Gene Therapy on Cardiovascular Disease Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global Gene Therapy on Cardiovascular Disease Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global Gene Therapy on Cardiovascular Disease Market Size and CAGR Forecast by Sales Channel (2023-2031)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure Gene Therapy on Cardiovascular Disease Example
Figure Global Gene Therapy on Cardiovascular Disease Revenue (Million $) Status and Outlook (2017-2031)
Figure Global Gene Therapy on Cardiovascular Disease Revenue (Million $) Comparison by Region (2017-2031)
Figure Global Gene Therapy on Cardiovascular Disease Revenue (Million $) Comparison by Type (2017-2031)
Figure Global Gene Therapy on Cardiovascular Disease Revenue (Million $) Comparison by Application (2017-2031)
Figure Global Gene Therapy on Cardiovascular Disease Revenue (Million $) Comparison by Sales Channel (2017-2031)
Table Global Gene Therapy on Cardiovascular Disease Sales by Player (2020-2022)
Table Global Gene Therapy on Cardiovascular Disease Sales Market Share by Player (2020-2022)
Figure Global Gene Therapy on Cardiovascular Disease Sales Market Share by Player in 2022
Table Global Gene Therapy on Cardiovascular Disease Revenue (Million $) by Player (2020-2022)
Table Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Player (2020-2022)
Figure Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Player in 2022
Table Global Gene Therapy on Cardiovascular Disease Average Price by Player (2020-2022)
Figure Global Gene Therapy on Cardiovascular Disease Average Price by Player in 2022
Figure Global Gene Therapy on Cardiovascular Disease Players Competition Situation ? Top 5 Players? Revenue Market Share in 2020
Figure Global Gene Therapy on Cardiovascular Disease Players Competition Trends ? Top 5 Players? Revenue Market Share in 2022
Figure Example of Viral Gene Therapy
Figure Global Viral Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Non-Viral Gene Therapy
Figure Global Non-Viral Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Table Global Gene Therapy on Cardiovascular Disease Sales by Type (2017-2022)
Table Global Gene Therapy on Cardiovascular Disease Sales Market Share by Type (2017-2022)
Figure Global Gene Therapy on Cardiovascular Disease Sales Market Share by Type in 2022
Table Global Gene Therapy on Cardiovascular Disease Revenue (Million $) by Type (2017-2022)
Table Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Type (2017-2022)
Figure Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Type in 2022
Table Global Gene Therapy on Cardiovascular Disease Average Price by Type (2017-2022)
Figure Global Gene Therapy on Cardiovascular Disease Average Price by Type in 2022
Table Leading Players of Gene Therapy on Cardiovascular Disease by Type in 2022
Figure Example of Heart Disease
Figure Global Gene Therapy on Cardiovascular Disease for Heart Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Vascular Disease
Figure Global Gene Therapy on Cardiovascular Disease for Vascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Table Global Gene Therapy on Cardiovascular Disease Sales by Application (2017-2022)
Table Global Gene Therapy on Cardiovascular Disease Sales Market Share by Application (2017-2022)
Figure Global Gene Therapy on Cardiovascular Disease Sales Market Share by Application in 2022
Table Leading Consumers of Gene Therapy on Cardiovascular Disease by Application in 2022
Figure Example of Direct Channel
Figure Global Gene Therapy on Cardiovascular Disease for Direct Channel Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Distribution Channel
Figure Global Gene Therapy on Cardiovascular Disease for Distribution Channel Revenue (Million $) and Growth Rate (2017-2022)
Table Global Gene Therapy on Cardiovascular Disease Revenue by Sales Channel (2017-2022)
Table Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Sales Channel (2017-2022)
Figure Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Sales Channel in 2022
Table Leading Distributors/Dealers of Gene Therapy on Cardiovascular Disease by Sales Channel in 2022
Table Global Gene Therapy on Cardiovascular Disease Market Size and CAGR by Region (2017-2031)
Table Global Gene Therapy on Cardiovascular Disease Sales by Region (2017-2022)
Table Global Gene Therapy on Cardiovascular Disease Sales Market Share by Region (2017-2022)
Figure Global Gene Therapy on Cardiovascular Disease Sales Market Share by Region in 2022
Table Global Gene Therapy on Cardiovascular Disease Revenue (Million $) by Region (2017-2022)
Table Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Region (2017-2022)
Figure Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Region in 2022
Table North America Gene Therapy on Cardiovascular Disease Sales by Country (2017-2022)
Figure North America Gene Therapy on Cardiovascular Disease Sales Market Share by Country (2017-2022)
Table North America Gene Therapy on Cardiovascular Disease Revenue by Country (2017-2022)
Figure North America Gene Therapy on Cardiovascular Disease Revenue Market Share by Country (2017-2022)
Figure North America Gene Therapy on Cardiovascular Disease Market Share by Type in 2022
Figure North America Gene Therapy on Cardiovascular Disease Market Share by Application in 2022
Figure United States Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure United States Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Canada Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Canada Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Mexico Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Mexico Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Table Europe Gene Therapy on Cardiovascular Disease Sales by Country (2017-2022)
Figure Europe Gene Therapy on Cardiovascular Disease Sales Market Share by Country (2017-2022)
Table Europe Gene Therapy on Cardiovascular Disease Revenue by Country (2017-2022)
Figure Europe Gene Therapy on Cardiovascular Disease Revenue Market Share by Country (2017-2022)
Figure Europe Gene Therapy on Cardiovascular Disease Market Share by Type in 2022
Figure Europe Gene Therapy on Cardiovascular Disease Market Share by Application in 2022
Figure Germany Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Germany Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure UK Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure UK Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure France Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure France Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Italy Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Italy Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Russia Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Russia Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Spain Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Spain Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Table Asia-Pacific Gene Therapy on Cardiovascular Disease Sales by Country (2017-2022)
Figure Asia-Pacific Gene Therapy on Cardiovascular Disease Sales Market Share by Country (2017-2022)
Table Asia-Pacific Gene Therapy on Cardiovascular Disease Revenue by Country (2017-2022)
Figure Asia-Pacific Gene Therapy on Cardiovascular Disease Revenue Market Share by Country (2017-2022)
Figure Asia-Pacific Gene Therapy on Cardiovascular Disease Market Share by Type in 2022
Figure Asia-Pacific Gene Therapy on Cardiovascular Disease Market Share by Application in 2022
Figure China Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure China Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Japan Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Japan Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Korea Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Korea Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure India Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure India Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Southeast Asia Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Southeast Asia Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Australia Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Australia Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Table South America Gene Therapy on Cardiovascular Disease Sales by Country (2017-2022)
Figure South America Gene Therapy on Cardiovascular Disease Sales Market Share by Country (2017-2022)
Table South America Gene Therapy on Cardiovascular Disease Revenue by Country (2017-2022)
Figure South America Gene Therapy on Cardiovascular Disease Revenue Market Share by Country (2017-2022)
Figure South America Gene Therapy on Cardiovascular Disease Market Share by Type in 2022
Figure South America Gene Therapy on Cardiovascular Disease Market Share by Application in 2022
Figure Brazil Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Brazil Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Argentina Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Argentina Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Colombia Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Colombia Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Table Middle East & Africa Gene Therapy on Cardiovascular Disease Sales by Country (2017-2022)
Figure Middle East & Africa Gene Therapy on Cardiovascular Disease Sales Market Share by Country (2017-2022)
Table Middle East & Africa Gene Therapy on Cardiovascular Disease Revenue by Country (2017-2022)
Figure Middle East & Africa Gene Therapy on Cardiovascular Disease Revenue Market Share by Country (2017-2022)
Figure Middle East & Africa Gene Therapy on Cardiovascular Disease Market Share by Type in 2022
Figure Middle East & Africa Gene Therapy on Cardiovascular Disease Market Share by Application in 2022
Figure UAE Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure UAE Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Saudi Arabia Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure Saudi Arabia Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure South Africa Gene Therapy on Cardiovascular Disease Sales and Growth Rate (2017-2022)
Figure South Africa Gene Therapy on Cardiovascular Disease Revenue (Million $) and Growth Rate (2017-2022)
Table Company Snapshot of Renovacor
Table Gene Therapy on Cardiovascular Disease Introduction of Renovacor
Table Gene Therapy on Cardiovascular Disease Sales, Price, Revenue, Gross Margin and Market Share of Renovacor (2020-2022)
Table Industrial Chain of Gene Therapy on Cardiovascular Disease
Table Manufacturing Cost Structure of Gene Therapy on Cardiovascular Disease
Table General Manufacturing Process of Gene Therapy on Cardiovascular Disease
Table Leading Distributors/Dealers of Gene Therapy on Cardiovascular Disease
Table Leading Consumers of Gene Therapy on Cardiovascular Disease
Figure Global Gene Therapy on Cardiovascular Disease Sales and Growth Rate Forecast (2023-2031)
Figure Global Gene Therapy on Cardiovascular Disease Revenue and Growth Rate Forecast (2023-2031)
Table Global Gene Therapy on Cardiovascular Disease Market Size and CAGR Forecast by Region (2023-2031)
Table Global Gene Therapy on Cardiovascular Disease Market Size and CAGR Forecast by Type (2023-2031)
Table Global Gene Therapy on Cardiovascular Disease Market Size and CAGR Forecast by Application (2023-2031)
Table Global Gene Therapy on Cardiovascular Disease Market Size and CAGR Forecast by Sales Channel (2023-2031)
